[Form 4] The Allstate Corporation Insider Trading Activity

Rhea-AI Filing Summary

Mark Q. Prindiville, Executive Vice President & Chief Risk Officer of The Allstate Corporation (ALL), reported option exercise and multiple open-market sales on 08/22/2025. He exercised employee stock options to acquire 7,383 shares at an exercise price of $62.32 (options granted 02/11/2019, exercisable through 02/11/2026) and immediately sold a series of shares: 3,019 shares at a weighted average of $205.3347, 1,265 shares at $206.8183, 2,984 shares at $207.3099, and 115 shares at $208.2636. Following these transactions, he beneficially owned 22,274 shares directly and 0 shares indirectly, with an additional 0 shares held indirectly through a 401(k) plan noted as 0. The Form 4 was signed by an attorney-in-fact on 08/26/2025.

Positive

• Exercise of options: Reporting person exercised 7,383 employee stock options at $62.32, converting compensation into shares.
• Full disclosure: Form includes weighted average sale prices and explanatory ranges for open-market sales with offer to provide per-price breakdowns on request.

Negative

• Large immediate dispositions: All 7,383 shares acquired via option exercise were sold in the market on the same date, reducing exposure.
• Reduced direct ownership: Post-transaction direct beneficial ownership declined to 22,274 shares.

Insights

Financial Analyst

TL;DR Insider exercised options and sold portions of newly acquired shares, leaving a reduced direct holding of 22,274 shares.

The reporting person exercised 7,383 employee stock options at $62.32, and executed multiple open-market sales totaling 7,383 shares on 08/22/2025 at weighted average prices between $205.33 and $208.26. The net effect is the conversion of option holdings into cash via market sales while retaining a direct beneficial position of 22,274 shares. These are routine Section 16 transactions reflecting option exercise and disposition; no additional company financial metrics or forward-looking statements are included in the filing.

Corporate Governance Expert

TL;DR Transactions appear compliant with Section 16 reporting: exercise, immediate sales, and disclosure of weighted average sale prices and remaining ownership.

The Form 4 discloses exercise of employee stock options and contemporaneous open-market sales with explanatory footnotes providing price ranges. The filing identifies the reporting person and relationship to the issuer (EVP & Chief Risk Officer) and reports post-transaction beneficial ownership. There is no indication in this form of trading pursuant to a 10b5-1 plan or any amendments; the form also notes availability of per-price sale breakdowns upon request, supporting disclosure completeness for these transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Prindiville Mark Q

(Last) (First) (Middle)

C/O THE ALLSTATE CORPORATION

3100 SANDERS ROAD

(Street)

NORTHBROOK IL 60062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALLSTATE CORP [ ALL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			EVP & Chief Risk Officer - AIC

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/22/2025		M		7,383	A	$62.32	29,657	D
Common Stock	08/22/2025		S		3,019	D	$205.3347(1)	26,638	D
Common Stock	08/22/2025		S		1,265	D	$206.8183(2)	25,373	D
Common Stock	08/22/2025		S		2,984	D	$207.3099(3)	22,389	D
Common Stock	08/22/2025		S		115	D	$208.2636(4)	22,274	D
Common Stock								0	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$62.32	08/22/2025		M			7,383	02/11/2019	02/11/2026	Common Stock	7,383	$0	0	D

Explanation of Responses:

1. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sales prices ranged from $205.015 to $205.965. The reporting person provided to the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

2. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sales prices ranged from $206.090 to $207.060. The reporting person provided to the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

3. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sales prices ranged from $207.090 to $208.0725. The reporting person provided to the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

4. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sales prices ranged from $208.090 to $208.380. The reporting person provided to the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

	/s/ Meghan E. Jauhar, attorney-in-fact for Mark Q. Prindiville	08/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Mark Q. Prindiville report on Form 4 for ALL?

He reported exercising 7,383 employee stock options at $62.32 and selling 7,383 shares in multiple open-market transactions on 08/22/2025.

How many shares does Prindiville beneficially own after these transactions?

The Form 4 reports 22,274 shares beneficially owned directly following the reported transactions.

At what prices were the open-market sales executed?

Weighted average sale prices reported were $205.3347, $206.8183, $207.3099, and $208.2636, with footnoted actual sale price ranges provided in the filing.

Were the options exercisable and when do they expire?

The exercised employee stock options were exercisable beginning 02/11/2019 with an expiration date of 02/11/2026.

Did the filing indicate trading under a 10b5-1 plan?

The Form 4 does not indicate that these transactions were made pursuant to a 10b5-1 plan; no checkbox for such a plan is marked in the provided content.